The tape has gotten defensive. SPY lost its 50-day, QQQ is back under its 200-day, and VIX is up almost 50% in a month. Over that same month XLV is +5%, XLP +6%, and XLK is −12%. Money is clearly hiding somewhere, and LLY is where a lot of it is going.
LLY is up 14% in a month and 19% in three, sitting above the 20/50/200-day, and it printed a new 52-week high at 1475 yesterday. The news flow helps too: the Calytrix Bio acquisition (up to $1.5B) and the Stipple Bio oncology deal (up to $5.9B) both landed this week, and the next earnings report isn't until February. So nothing scheduled should blow this up over the next few weeks.
I'm not chasing it here though. Yesterday tagged 1475 and closed at 1431, which is a pretty ugly long wick, and it could easily turn into a failed breakout. I'd rather buy the pullback.